Skip to main content
. 2020 Jun 23;12(6):1661. doi: 10.3390/cancers12061661

Figure 2.

Figure 2

ROS level is upregulated upon BRAF and MEK inhibitor resistance. (A) ROS levels in WM-115 (parental, dabrafenib-resistant (DR), and trametinib- and dabrafenib-resistant (TDR) and WM-983 (parental, DR, and TDR) were measured by the DCFDA assay. (B) Basal superoxide levels in WM-115 (parental, DR, and TDR) and WM-983 (parental, DR, and TDR) cells were measured by the MitoSOX assay. * p < 0.05 versus parental cell lines. Statistical analysis by one way ANOVA.